Company news
Vericel Corporation (NASDAQ:VCEL) news
Vericel Corporation news releases on 6ix. Latest, Sep 8, 2026: Vericel to Present at the 24th Annual Morgan Stanley Global Healthcare Conference on Tuesday…
Press releases & updates
Vericel to Present at the 24th Annual Morgan Stanley Global Healthcare Conference on Tuesday, September 15, 2026
September 8, 2026
Vericel Reports Second Quarter 2026 Financial Results, Raises Full-Year Financial Guidance and Announces Share Repurchase Program
July 30, 2026
Vericel to Report Second Quarter 2026 Financial Results on July 30, 2026
July 16, 2026
Vericel to Present at the 2026 Truist Securities MedTech Conference on Tuesday, June 16, 2026
June 8, 2026
Carticel Sm Service (Vericel) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F
May 7, 2026
Vericel to Report First-Quarter 2026 Financial Results on May 7, 2026
April 22, 2026
Vericel Announces BARDA Award Valued at up to $197 Million for Procurement and Advanced Development of NexoBrid
April 1, 2026
Vericel Announces FDA Approval of New State-of-the-Art Advanced Therapy Manufacturing Facility
March 3, 2026
Vericel Reports Fourth Quarter and Full-Year 2025 Financial Results
February 26, 2026
Vericel to Report Fourth-Quarter and Full-Year 2025 Financial Results on February 26, 2026
February 12, 2026
Vericel Announces Preliminary 2025 Financial Results and Business Updates
January 12, 2026
Vericel to Present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026
January 5, 2026
Vericel to Present at the Stephens Annual Investment Conference on Thursday, November 20, 2025
November 13, 2025
Vericel Reports Third Quarter 2025 Financial Results
November 5, 2025
Vericel to Report Third-Quarter 2025 Financial Results on November 6, 2025
October 22, 2025
Vericel to Present at the Wells Fargo Healthcare Conference on Thursday, September 4, 2025
August 27, 2025
Vericel Reports Second Quarter 2025 Financial Results
July 30, 2025
Vericel to Report Second-Quarter 2025 Financial Results on July 31, 2025
July 16, 2025
Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 17, 2025
June 9, 2025
Vericel Reports First Quarter 2025 Financial Results and Raises Full-Year Profitability Guidance
May 7, 2025
Vericel to Present at the Bank of America Securities 2025 Healthcare Conference on Wednesday, May 14, 2025
May 6, 2025
Vericel to Report First-Quarter 2025 Financial Results on May 8, 2025
April 23, 2025
Vericel to Present at Multiple Upcoming Investor Conferences
March 3, 2025
Vericel Reports Fourth Quarter and Full-Year 2024 Financial Results
February 26, 2025
Vericel to Report Fourth-Quarter and Full-Year 2024 Financial Results on February 27, 2025
February 12, 2025
Vericel Announces Preliminary 2024 Financial Results, 2025 Financial Guidance and Increased Mid-Term Profitability Targets
January 13, 2025
Vericel to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025
January 7, 2025
Vericel Reports Third Quarter 2024 Financial Results
November 6, 2024
Vericel to Report Third-Quarter 2024 Financial Results on November 7, 2024
October 23, 2024
Vericel to Present at the Morgan Stanley Global Healthcare Conference on Friday, September 6, 2024
August 28, 2024
Vericel Announces FDA Approval and Commercial Availability of MACI Arthro
August 25, 2024
Vericel Announces FDA Approval of NexoBrid for the Treatment of Pediatric Patients with Severe Thermal Burns
August 14, 2024
Vericel to Present at the Canaccord Genuity Growth Conference on Wednesday, August 14, 2024
August 6, 2024
Vericel Reports Second Quarter 2024 Financial Results
July 31, 2024
Vericel Announces Appointment of Karen Mahoney as Chief Human Resources Officer
July 21, 2024
Vericel to Report Second-Quarter 2024 Financial Results on August 1, 2024
July 17, 2024
Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 18, 2024
June 10, 2024
Vericel to Present at the Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, 2024
May 21, 2024
Vericel Reports First Quarter 2024 Financial Results and Raises Full-Year 2024 Financial Guidance
May 7, 2024
Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024
April 23, 2024
Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance
February 28, 2024
Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024
February 26, 2024
Vericel to Report Fourth-Quarter and Full-Year 2023 Financial Results on February 29, 2024
February 14, 2024
Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024
February 4, 2024
Vericel Announces Preliminary Full-Year and Fourth Quarter 2023 Financial Results
January 8, 2024
Vericel to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024
January 2, 2024
Vericel Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance
November 7, 2023
Vericel to Present at the Stephens Annual Investment Conference
November 6, 2023
Vericel to Report Third-Quarter 2023 Financial Results on November 8, 2023
October 24, 2023
Vericel Announces Publication of Positive Results from Phase 3 Debride and Protect (DETECT) Study of Thermal Burn Patients Treated with NexoBrid
September 27, 2023